Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
long COVID; developed "auto-immune" problems; developed COVID19; developed COVID19; interchange of vaccine products; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. An adult female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Moderna vaccines (Primary immunization series completed), for Covid-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset Oct2022, outcome "unknown"; DRUG INEFFECTIVE (medically significant) and COVID-19 (medically significant) both with onset Nov2022, outcome "unknown", described as "developed COVID19"; POST-ACUTE COVID-19 SYNDROME (medically significant), outcome "unknown", described as "long COVID"; IMMUNE SYSTEM DISORDER (non-serious), outcome "unknown", described as "developed "auto-immune" problems". Clinical course: Reporter states received a Pfizer mRNA shot in Oct2022 (after receiving the Moderna vaccines for her primary series). She states that she developed COVID19 in Nov2022. Since that time, she stated she has developed autoimmune problems and wonders if she has "long COVID". It was unknown if patient received any other vaccines on the same date as the vaccine and 4 weeks prior to the vaccine. It was also unknown if the patient was taking any other medication 2 weeks prior to the event starting The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Allergy